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Abstract
Diseases and defects of the temporomandibular joint (TMJ), compromising the cartilaginous layer
of the condyle, impose a significant treatment challenge. Different regeneration approaches,
especially surgical interventions at the TMJ's cartilage surface, are established treatment methods
in maxillofacial surgery but fail to induce a regeneration ad integrum. Cartilage tissue engineering, in
contrast, is a newly introduced treatment option in cartilage reconstruction strategies aimed to
heal cartilaginous defects. Because cartilage has a limited capacity for intrinsic repair, and even
minor lesions or injuries may lead to progressive damage, biological oriented approaches have
gained special interest in cartilage therapy. Cell based cartilage regeneration is suggested to
improve cartilage repair or reconstruction therapies. Autologous cell implantation, for example, is
the first step as a clinically used cell based regeneration option. More advanced or complex
therapeutical options (extracorporeal cartilage engineering, genetic engineering, both under
evaluation in pre-clinical investigations) have not reached the level of clinical trials but may be
approached in the near future. In order to understand cartilage tissue engineering as a new
treatment option, an overview of the biological, engineering, and clinical challenges as well as the
inherent constraints of the different treatment modalities are given in this paper.
Introduction
Skeletal defects in the adults craniofacial skeleton com-
promises mainly bony structures, whereas chondral or
osteochondral defects are less common, but when present
are accompanied by a significant morbidity. Articular car-
tilage tissue is present in the adult patient in the temporo-
mandibular joint (TMJ). Despite this relative minor
prevalence of cartilage defects towards bony destructions,
defects of the TMJ plays an important clinical role in max-
illofacial surgery [1]. The consequences oft TMJ tissue
alteration may be pain and functional impairments. Dis-
turbances in the cartilage layer are often associated with
severe functional disturbances and a subsequent progres-
sion of cartilage degeneration or inflammation. Diseased
or lost TMJ structures are most common as sequelae of
trauma, degeneration, infection, or autoimmune disease.
The treatment of TMJ defects is complex and based mainly
on the underlying cause of defect generation [2]. Indica-
tions for a surgical management can be devided in relative
and absolute indications. Due to the multitude of patho-
genic disturbances and based on the extent of TMJ struc-
ture involvement attempts to heal TMJ lesions span the
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sive surgical interventions. Absolute indications are com-
monly reserved for more severe alterations of the TMJ disc
or the condyle. Whereas interventions at the base of the
skull are seldom performed, repair of the disc or the con-
dyle is a matter of special interest in maxillofacial surgery.
The spectrum of surgical procedures for the treatment of
temporomandibular joint disorders is wide and ranges
from simple arthrocentesis and lavage to more complex
open joint surgical procedures. The most invasive proce-
dure is the resection and reconstruction of the TMJ. Autol-
ogous cartilage-bone grafts, e.g. from the rib, and
alloplastic materials like a patient-fitted prostheses can be
used for the reconstruction of the joint. The issue on engi-
neering the TMJ disc, reviewed extensively by Allan and
Athanasiou [3], is from a structural and biological aspect
distinct from those at the cartilage containing condylar
head [4].
As articular cartilage has, in contrast to bone, only a lim-
ited capacity to regenerate itself, regeneration supporting
therapies are of high relevance when this tissue is involved
in the destruction process [5]. It is well known that lesions
which are confined to the articular cartilage alone have lit-
tle or no capacity to heal. In general, the patients become
symptomatic and a significant progression to osteoarthri-
tis is possible [6]. Those lesions that penetrate the
subchondral bone have a limited repair capacity because
they have access to the bone marrow space and chondro-
progenitor cells. The regeneration and repair of lesions in
the condylar head depend therefore on the extent of
destruction and, when being severe, impose a significant
problem in maxillofacial practice. That is why new thera-
peutic strategies focus on cartilage tissue engineering strat-
egies to regenerate or reconstruct condylar cartilage [4,7].
As an unimpaired biomechanical function of articular car-
tilage containing joints is dependant on the anatomical
integrity of the joint [8], custom made engineered struc-
tures are of importance [9]. As cartilage defects are typi-
cally seen in arthrotic or arthritic patients, cartilage
engineering may be today of special relevance in these
patient groups but may be in future also used to repair
more complex cases.
It is important to note that in contrast to maxillofacial sur-
gery, where recently the economically most important
skeletal tissue substitute is bone, cartilage plays the most
prominent role in orthopaedics [10]. Cartilage engineer-
ing therapies were mainly invented and tested in the
orthopaedic field but are now introduced in maxillofacial
surgery. Based on a multitude of valuable basic scientific,
pre-clinical as well as clinical studies, advances have been
made in all fields of cartilage tissue engineering. The
review is intended to give an updated overview of cartilage
tissue engineering. To understand the evolving field of
cartilage engineering it is important to give a brief intro-
duction in cartilage histology and cartilage regeneration
and to consider the common repair procedures, before the
field of cartilage tissue engineering in the narrower sense
is discussed in detail.
Cartilage histology
The three types of cartilage (hyaline cartilage, elastic carti-
lage, and fibrocartilage) are present in adults. The type of
cartilage differs in the various locations of the body (at the
articular surface of bones, in the trachea, bronchi, nose,
ears, larynx, and in intervertebral disks). The cartilage of
the condylar head is fibroelastic [11]. The histology of the
condyle mirrors the functional needs of mandibular
movement [12]. The cartilage cap of the joint contains
cells, fibers, and amorphous ground substance. It is dom-
inated by the acellular elements and is devoid of blood
vessels and nerves. Cartilage is occupied by an extensive
extracellular matrix that is synthesised by chondrocytes. A
chondrocyte always generates from a mesenchymal cell,
the prechondrogenic cell or chondrocyte precursor cell,
which is – due to lack of specific markers – only defined
by the expectation that its daughter cell will be a differen-
tiated chondrocyte (for review see Behonick and Werb
[13]). Chondrocyte precursor cells are of general fibrob-
lastic appearance and synthesises – like fibroblasts – type
I and III collagen, fibronectin, and noncartilage-type pro-
teoglycans [14]. Stem cells with chondrogenic potential
persist throughout adult life and can be induced to differ-
entiate into chondrocytes during fracture callus forma-
tion, osteophyte formation, or as ectopic cartilage.
At its free (superficial) surface, which is contacted by syn-
ovial fluid, the chondrocytes are flattened and aligned
parallel to the surface (for review see Poole et al. [15]).
Below the superficial zone is the midzone where cell den-
sity is lower. The ultrastructure of the midzone reveals
more typical morphologic features of a hyaline cartilage
with more rounded cells and an extensive extracellular
matrix. Between this midzone and the layer of calcified
cartilage is the deep zone. Deep to the articular cartilage,
and separated from it, is a layer of calcified cartilage. The
calcified cartilage is not very vascular normally, and the
remodeling process is therefore not as effective as in vas-
cularised locations. Cell density is lowest in this zone. The
chondrocytes in the calcified zone usually express the
hypertrophic phenotype, reaching a stage of differentia-
tion that can also be found in fracture repair. The calcified
interface provides excellent structural integration with the
subchondral bone. Subchondral trabecular bone is under-
lying the subchondral plate. The structure and appearance
of subchondral bone, being critically dependent on the
load situation of the TMJ [16], changes its density by
remodelling [17]. The extracellular matrix of fibrocarti-
lage is composed of differentially distributed collagenPage 2 of 7
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sive network. Many of the molecules play a structural role,
whereas others may be involved in regulating cell func-
tion. The ground substance of articular cartilage contains
also a large variety of noncollagenous proteins and
polysaccharides. The molecules vary in their abundance
and structure with anatomical site or the person's age.
There are no common features of non-collagenous pro-
teins in respect to their distribution, structure and func-
tion. Many of the molecules are proteoglycans, bearing
glycosaminoglycan chains, whereas others are glycopro-
teins or even nonglycosylated proteins.
Cartilage regeneration
Cartilage is a metabolically active tissue that under nor-
mal conditions is maintained in a relatively slow state of
turnover by a sparse population of chondrocytes distrib-
uted throughout the tissue. Despite the activity of these
cells, cartilage has a limited capacity for intrinsic repair,
and even minor lesions or injuries may lead to progressive
damage (and in case of articular cartilage leads to subse-
quent joint degeneration) [18-20]. Isolated chondral or
osteochondral lesions also may be a significant source of
pain and loss of function, and will heal spontaneously
only under some circumstances. The repair of cartilage is
critically dependent on the extent of tissue destruction.
Based on the extent of tissue damage, articular defects can
be classified into three types:
- mechanical disruption of articular cartilage limited to
articular cartilage
- damage to the cells and matrices of articular cartilage and
subchondral bone
- mechanical disruption of articular cartilage and bone
Each type of tissue damage initiates a distinct cell driven
repair response [21-23]. The ability of chondrocytes to
sense changes in matrix composition and synthesise new
molecules are the basis for repair processes [24-27]. The
two features that are assumed to play main roles in the
limited repair response of articular cartilage are the lack of
blood supply and a lack of undifferentiated cells that can
promote repair. Chondrocytes can repair defects ad inte-
grum in circumstances where the loss of matrix proteogly-
cans does not exceed what the cells can rapidly produce, if
the fibrillar collagen meshwork remains intact, and if
enough chondrocytes remain capable of responding to
the matrix damage.
The repair and remodeling of osteochondral defects dif-
fers from the events that follow injuries that cause only
cell and matrix injury or disruption of the articular surface
limited to articular cartilage [28]. The extent and outcome
of the repair and remodeling responses is critically
dependant on the desintegration of the subchondral tis-
sue. Defects that extend into subchondral bone cause, in
contrast to superficial defects, bleeding into the defect
area. Soon after full thickness defects are present, blood
escaping from the damaged subchondral bone forms a
hematoma that fills the injury site. The final outcome of
the repair tissue typically has a composition and structure
intermediate between hyaline cartilage and fibrocartilage,
imposing an impaired biomechanical competence. The
newly formed tissue is in structure and biomechanical
competence different to normal articular cartilage
[21,22,24,25,29] imposing decreased stiffness and
increased permeability. The impact of load on cartilage
structure and function is of outermost importance. Physi-
ologic TMJ loading maintains cartilage structure and func-
tion. In the context of articular cartilage repair, it is
important to recognise that stresses in a cartilage defect or
the surrounding tissue may be altered significantly from
their normal mechanical environment, and therefore
impairs tissue integrity before and after cell/scaffold
implantation.
Surgical repair strategies
In maxillofacial surgery, there are two general goals for
cartilage reconstruction. The first is the immediate need
for clinical pain relief and restoration of joint function.
The second goal is to prevent or at least delay the onset of
subsequent joint alterations. From a practical perspective,
the current objective of articular cartilage repair is to avoid
the development of a deformed joint surface [30]. Besides
non-surgical therapies that are based on the administra-
tion of drugs (non-steroidal antiphlogistics, steroids) and
biologicals (hyaluronan), surgical options play a signifi-
cant role aimed to gain pain relief, to restore joint func-
tionality and to prevent progression of joint destruction,
especially in severely altered joints. In some instances
drastic measures like total TMJ replacement by TMJ pros-
thesis are necessary to achieve clinical success, but such
measures impose the problem of long term complications
(material failure, scull base perforation) especially when
used in younger patients. The use of alloplastic materials
is therefore a matter of controversy in maxillofacial sur-
gery [1]. Dimitroulis [2] stresses in his review on TMJ sur-
gery the demands of a close adaptation to natural tissues
when a long term success is envisioned. Most of the exper-
imental and clinical attempts that have hence been made
to restore articular cartilage structure aim at re-establish-
ment of biomechanically competent tissue of an enduring
nature [31]. The surgical measures to improve temporo-
mandibular joint structure and function without the use
of biologically active substances can be conceptualised as
methods to improve the condition of the joint fluids (lav-
age), to mechanically remove diseased or necrotic superfi-
cial chondral tissue (shaving, debridement, laserPage 3 of 7
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(abrasion chondroplasty, pridie drilling, microfracture
techniques and spongialisation). The underlying reason
for lavage or debridement is the removal of inflamed or
diseased tissue, whereas the method to gain access to
subchondral bone is aimed at initiating a spontaneous
healing response. Arthroscopic lavage and debridement
are often used to alleviate joint pain. Lavage is mainly per-
formed by arthroscopy. Various other methods like free
[32] or vascularised tissue transfer [33] are clinically used,
but some of these approaches impose unexpected clinical
outcomes [34]. In contrast to the orthopeadic field, where
an ankylosis of a joint may be the ultimate treatment ratio
for complicated cases, iatrogenic ankylosis seems not to
be indicated for the TMJ in any clinical situation.
Cellular repair strategies
The use of cells or cell-containing devices, considered to
be tissue engineering strategies, can be performed by dif-
ferent measures [35-37]. Tissue engineering techniques
have seen rapid advances and refinements during the last
years. Whereas these techniques have been elaborated
mainly by orthopaedics, their principle application refers
also to the maxillofacial field. Transplants from either
autologous or allogenic origin can be harvested in the
form of perichondrial or periosteal tissue and as a bulk
osteochondral part. Perichondrial or periosteal autotrans-
plantation as a single procedure has been exploited in a
variety of protocols elaborated for the treatment of articu-
lar cartilage defects. Other tissue engineering concepts
such as autologous chondrocyte transplantation (ACT)
delivers chondrogenic precursor cells to the defect site.
The basic biological principle behind the use of these cell
based techniques is the fact that perichondrial and perio-
steal tissue as well as isolated cell suspensions (ACT) con-
tains cells that possess a life-long chondrogenic potential.
A pool of precursor or adult-type stem cells is assumed to
be present in these tissues that render self-renewable
capacity and are able to induce tissue healing. Implanta-
tion of explanted bulk chondral or osteochondral tissue
(mosaicplasty), routinely used in orthopaedic joint and
bone surgery but seldom applied in the TMJ region [4], is
aimed to repair mid-size chondral or osteochondral
defects. Experimental studies revealed that graft material
persisted for a short time, however, long-term effects are
not extensively evaluated. It was demonstrated by retro-
spective studies that clinical outcomes were acceptable in
sense of improved joint functionality and pain relief.
Despite the short-term clinical success, the use of non
expanded autografts possess a number of disadvantages.
The donor site may experience severe morbidity since the
explantation site will loose as much chondral or osteo-
chondral tissue as the diseased implantation site will get.
Transplantation of extended cartilage containing speci-
mens (iliac crest, digits) [33] are seldom performed in TMJ
surgery due to the significant functional impairment in
the harvesting region.
Articular chondrocytes are responsible for the unique fea-
tures of articular cartilage; hence, it seemed rational to use
committed chondrocytes to repair a cartilaginous defect.
As cells were demonstrated to impose the ability to be
expanded in culture the re-transplantation of ex-vivo mul-
tiplicated cells (autologous chondrocyte transplantation
(ACT)) seemed to be a promising treatment strategy. Over
the last decade autologous chondrocyte transplantation
has gained much scientific and commercial interests. ACT
and its several modifications are the most widespread
applications of cartilage tissue engineering. In the clinical
use of in vitro expanded autologous chondrocytes for car-
tilage repair the aim seemed to be to have an adequate
number of expanded cells to implant and an overlying
membrane to avoid cell and matrix loss. Brittberg etal.
[38] successfully reported in 1994 on autologous
chondrocyte implantation using a monolayer culture sys-
tem to treat cartilage defects. In this procedure, harvested
autologous chondrocytes, expanded in a monolayer cul-
ture system were transplanted to an osteochondral lesion
which was covered by a periosteal flap. The rationale
behind this approach was the finding that chondrocytes
can, after harvesting, be isolated by enzymatic digestion
and expanded in culture 20 to 50 times the initial number
of cells [39]. It is known that cells, cultured in monolayers
with serum supplementation in the culture media, com-
mence to dedifferentiate. The dedifferentiated chondro-
cytes share features of primitive mesenchymal cells and
on implantation at high density the in-vitro expanded
primitive immature chondrocytes imitate prechondroge-
neic cell condensation and cartilage formation [40,41].
This findings and the initial report by Brittberg had a high
impact on cartilage surgery and was regarded as a break-
through for cell-based cartilage repair strategies. The
United States Food and Drug Administration approved in
1997 the cell technology that uses the patient's own
chondrocytes to repair cartilage injuries in the knee [42].
This was the first type of cell technology that was regulated
by industry for use in expanding autologous cells for
human transplantation. In the U.S.A. and Europe, cell
processing in a monolayer culture is now been carried out
on a commercial basis. The use of autologous chondro-
cytes was primarily performed in traumatically damaged
knee joints [43]. Based on the sum of the experience
gained in orthopaedics, preclinical and clinical studies
tended to expand the indications to joints others than the
knee. To date ACT is clinically used to treat also non-trau-
matic cartilage defects (arthrosis, arthritis defects), and to
repair complex tissue defects (osteochondral defects) by a
combination of bone and cartilage products. As a conse-
quence, ACT is now under investigation as a clinical treat-
ment modality also in TMJ surgery.Page 4 of 7
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stressed. In contrast to the clinical outcome rates, limited
information is present on the histogenesis of the cell-
driven human repair tissue. Biopsy specimens from
grafted areas in individuals obtained after autologous
chondrocyte transplantation (in the orthopaedic field)
indicated that the ACT procedure helps to build up a tis-
sue with hyaline and fibrocartilage-like features [44,45].
Transarthroscopic biopsy specimens obtained from
grafted areas demonstrated in general a heterogeneity
throughout the repair tissue. Although beneficial short- or
middle-term clinical results were reported on a clinical
basis [45,46], the ACT procedure has potential disadvan-
tages, such as the risk of leakage of transplanted chondro-
cytes from the cartilage defects and an uneven distribution
of chondrocytes in the transplanted site [47]. Addition-
ally, ACT transplantation is not able to regenerated larger
defects. These limitations explain to some extent the find-
ing of a heterogenous tissue formation in the defect site.
To overcome these limitations, further developments
focus therefore on the ex-vivo growth of a three dimen-
sional cartilage-like tissue, which integrates intimately in
the defect site after being implanted. Other possible
sources of cells for tissue engineering include beneath
autologous cells allogenic and xenogenic cells. Each cate-
gory can be subdivided according to whether the cells are
in a more or less differentiated stage. Various mature cell
lines as well as multipotential so-called mesenchymal
progenitors have been successfully established [48] in
bone tissue engineering approches. Moreover, there are
some reports using totipotent embryonic stem cells for tis-
sue engineering of bone [49,50]. Another group of cells,
which is a special focus of scientific and clinical studies
today, is believed to contain multipotential stem cells
which are often called "mesenchymal stem cells (MSCs)"
[51,52] or "adult stem cells" [53]. Whereas the situation
of determined cells is well known to researchers and clini-
cians in TMJ reconstruction, not only the origin, but also
the destiny and clinical usefulness of MSCs in TMJ surgery
has not been entirely resolved to date.
In-vitro engineering strategies
In order to prevent the loss of chondrocytes after cell
implantation (in the case of ACT) and to increase the size
of a cellular device, extracorporal tissue engineering tech-
niques were considered an alternative pathway [7]. Extra-
corporal cartilage engineering requires not only living
chondrocytes, but additionally the interaction of two
other components: extracellular scaffolds and in some
instances growth factors. For engineering cartilage tissue
in-vitro cultured cartilage cells are cultured as described for
the ACT procedure in monolayer to increase the cell
number. Later on they are grown on two-dimensional or
three dimensional bioactive degradable biomaterials that
provide the physical and chemical basis to guide their dif-
ferentiation and three dimensional assembly [54]. In bio-
reactors outside the body the cellular device is ideally
matured to a cartilage-like tissue. New approaches in
extracorporal tissue engineering strategies are aimed to
improve chondrocyte cell lines and to fabricate scaffold-
free three-dimensional micro-tissue constructs. Whether
the cell containing device contains an artificial scaffold or
not [4], the construct has to be implanted in the defect site
to promote cartilage healing. An appropriate method to
gain this scaffold-free three-dimensional micro-tissue
might be the micromass technology. Cells are dissociated
and the dispersed cells are then reaggregated into cellular
spheres. The micromass technology relies to a great extend
on the presence of proteinacious extracellular matrix. The
extracellular matrix may exert direct and indirect influ-
ences on cells and consequently modulate their behav-
iour. In contrast to conventional monolayer cell cultures,
the three-dimensional spheres exert higher proliferation
rates and their differentiation more closely resembles that
seen in situ [55].
Most chondrocyte transplantation studies have, to date,
predominantly focussed on the use of an unselected
source of chondrocytes [38]. In the ongoing search to
improve chondrocyte cell lines, the use of specific
chondrocyte populations are now being considered to
investigate whether an improved cartilaginous structure
would be generated in-vivo and in-vitro by these specifi-
cally selected populations of determined chondrocytes
[56]. As distinct phenotypic and functional properties of
chondrocytes across the zones of articular cartilage are
present, it seemed reasonable to search for the best source
of chondrocyte subpopulations [57]. It was reported in
this respect that a combination of mid and deep zone
chondrocytes seems to be more suitable for the ex-vivo
generation of a hyaline-like cartilage tissue. Dowthwaite et
al. [58], have recently reported on an isolation technique
for chondrocytes that reside in the superficial zone of
immature bovine articular cartilage. These cells, character-
ised as determined chondrogenic cells, were shown to
allow appositional growth of the articular cartilage from
the articular surface [59]. Therefore, when chondrocytes
are aimed to generate a cartilage-like structure ex-vivo, it
seems to be reasonable not to gain full thickness cartilage
implants but to use subpopulations of chondrocytes. Sep-
aration of cartilage zones after the explantation and before
cultivation with a selective subpopulation may provide a
tool to improve tissue engineering strategies using deter-
mined cells. Phenotypic plasticity was tested by a series of
in-ovo injections where colony-derived populations of
these chondroprogenitors were engrafted into a variety of
connective tissue lineages thus confirming that this popu-
lation of cells have properties akin to those of a progenitor
cell. The high colony forming ability and the capacity to
successfully expand these progenitor populations in-vitroPage 5 of 7
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ment and growth and may provide novel solutions in ex-
vivo cartilage tissue engineering strategies.
Many attempts have been successfully undertaken to
refine procedures for the propagation and differentiation
of cells by the use of bioreactors [60] or by the use of pre-
cursor cells. The use of stem cells offers new perspectives
in cell propagation techniques. At present, adult stem cells
are able to differentiate into chondrocyte-like cells which
are competent to synthesise a cartilage-like extracellular
matrix under in vitro conditions. Despite the various
advantages of using tissue-derived adult stem cells over
other sources of cells, there is some debate as to whether
large enough populations of differentiated cells can be
grown in-vitro rapidly enough when needed clinically. The
alternative approach of using embryonic stem cells is
advantageous in respect to the nearly unlimited capacity
of cell multiplication but the clinical use of embryonic
stem cells is restricted through legal and ethical issues. The
use of unrestricted somatic stem cells (USSC's) gained
through umbilical cord blood seems, from a clinical per-
spective the most promising stem cell approach to date
[61]. These cells can be gained from stem cell banks, indi-
vidually matched prior transplantation, and transplanted
without major medical or legal restrictions. Whereas vari-
ous problems must be considered as a limitation for the
use of stem cells in extracorporal cartilage tissue engineer-
ing, the use of USSC's is in the clinical testing phase.
Whereas more basic research is necessary to assess the full
potential of stem cell therapy to reconstitute chondral
defects, such therapies may be one treatment option in
the near future. In this respect it is important to note that
many basic research and preclinical studies are today
directed toward the development of gene therapy proto-
cols employing gene insertion strategies [62].
Conclusion
Cartilage tissue engineering has seen significant improve-
ments in the basic research field as well as in pre-clinical
applications. Whereas a lot of these techniques are rou-
tinely used (or at least) have gained entrance in clinical tri-
als in orthopaedic surgery, less acceptance can be found in
maxillofacial surgery [63]. This may be based to some
extent on the specific requirements in TMJ surgery, but
from a biological perspective it can be assumed that it may
be approached more often in maxillofacial surgery in the
next future.
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